NEW YORK, April 1, 2024 /PRNewswire/ -- The Accreditation Council for Medical Affairs (ACMA) Think Tank will conduct research, analyze complex issues, and provide informed policy recommendations. The goal is to contribute to informed decision-making in the pharmaceutical industry by offering expertise on various topics, influencing public discourse, and assisting policymakers in developing effective strategies. This aligns with the ACMA mission to raise standards in the pharmaceutical industry.
"The cost of poor. Strategic decisions can hurt a pharmaceutical company, especially during drug launch, said Mena Boules, MD, senior pharmaceutical industry executive.
Identifying and mitigating risks prior to product launch are top priorities for regulatory agencies and pharmaceutical companies alike.
"In the dynamic landscape of healthcare, a pharmaceutical industry think tank serves as a beacon of innovation and expertise, fostering collaborative research and thought leadership" said William Soliman PhD, BCMAS, Founder of the ACMA.
"We are Guided by a commitment to advancing patient care, it shapes the future of medicine through insightful analysis and strategic recommendations, driving positive change and breakthroughs in the pursuit of global health excellence" said Dr. Soliman.
About the Accreditation Council for Medical Affairs (ACMA)
The ACMA is a globally recognized organization and leader focused on raising the bar in the pharmaceutical, biotech, medical devices, and diagnostics industries. The ACMA provides a full suite of certification, artificial intelligence SaaS solutions as well as prior authorization staffing services and market access advisory support for the pharmaceutical industry.
To learn more about the ACMA visit https://www.medicalaffairsspecialist.org
CONTACT: Vivian Chen, 1-855-255-7137, [email protected]
SOURCE Accreditation Council for Medical Affairs
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article